Latest News
SLT laser
SLT laser is a form of "cold laser" that does not burn the trabecular meshwork - rather it stimulates it to enhance drainage of fluid out of the eye. The results are modestly impressive - 5 year results indicate a 20-30% drop in eye pressure. It is a treatment that can be repeated, and surgery to control pressure can be delayed or postponed indefinitely as a result.Latest items
Popular
Glaucoma news
Memantine is a new drug for glaucoma, that has undergone extensive trials to establish its effectiveness. Disappointingly, it has not demonstrated the benefits expected, and plans to release this medication in the UK are therefore on hold.News
| Pros and cons of SLT |
|
|
|
| Written by Administrator | |
| Wednesday, 14 November 2007 | |
SLT does not rely on medicines, instead, uses an advanced laser system to target only specific cells of the eye—those containing melanin, a natural pigment. This allows for only these cells to be affected, leaving surrounding tissue in tact. As a result, your body's own healing response helps lower the pressure in your eye. There is not really a disadvantage of SLT compared to other available treatments. Mostly drop use and preservative toxicity is minimised as fewer drops are usually required after surgery, and the procedure is free of systemic side effects.
Advantages of the SLT procedure:
Click here for contact information for Selective Laser Trabeculoplasty
S. Melamed MD, Ben Simon MD, H. Levkovitch-Verbin MD. Selective Laser Trabeculoplasty as Primary Treatment for Openangle Glaucoma. Arch Ophthalmol. 2003; 121:957-960. Noecker RJ, Kramer TR. Comparison of the acute morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology, Apr 2001; 108(4):773-9. Alvarado JA, Latina MA, Damji KF, Katz LJ. The Science Underlying Selective Laser Trabeculoplasty. Ophthalmology Management, June 2002. |
|
| Last Updated ( Thursday, 15 November 2007 ) |
| < Prev |
|---|




